Literature DB >> 9476721

Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.

C C Huang1, N S Chu.   

Abstract

Dystonia is a common manifestation in Wilson's disease (WD). The striatum, especially the putamen, has been considered to be responsible for dystonia. We reported 3 patients who developed acute generalized dystonia and akinetic rigid syndrome following an initial therapy with d-penicillamine 125-500 mg daily. Brain MRI revealed lesions in the thalamus and the brainstem, particularly the tegmentum, and the basis pontis in addition to the basal ganglion lesions. After the episode, 1 patient continued to receive d-penicillamine therapy and 2 changed to zinc sulfate treatment. The generalized dystonia improved in the following 3 months and 3 years respectively in 2 patients. Follow-up brain MRI of these 2 patients revealed that the lesions in the thalamus and brainstem disappeared or resolved almost completely. From these data, acute generalized dystonia with brainstem and thalamic lesions may occur in WD patients after an initial d-penicillamine therapy. Furthermore, the dystonia may resolve following the disappearance of the brainstem and thalamic lesions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9476721     DOI: 10.1159/000007894

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  3 in total

1.  Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.

Authors:  M Hermes-Lima; M S Gonçalves; R G Andrade
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

Review 2.  Decreased T2 signal in the thalami may be a sign of lysosomal storage disease.

Authors:  Taina Autti; Raimo Joensuu; Laura Aberg
Journal:  Neuroradiology       Date:  2007-03-03       Impact factor: 2.804

3.  Microstructure changes in whiter matter relate to cognitive impairment in Wilson's disease.

Authors:  Ting Dong; Wen-Ming Yang; Ming-Cai Wu; Juan Zhang; Peng Huang; Chun-Sheng Xu; An-Qin Wang; Chun-Jun Kuang; Zhi-Ling Gao
Journal:  Biosci Rep       Date:  2019-03-15       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.